James Bascharon, DVM, is the founder and CEO of Vetnique, a pet health company dedicated to creating vet-formulated solutions that help pets thrive for life. Since launching in 2012 with the groundbreaking supplement Glandex for anal gland health, Bascharon has led Vetnique to become a leader across multiple categories including digestive support, dermatology, ear care, and joint health. His passion for innovation has guided the company’s rapid growth—most recently marked by Vetnique’s acquisition and US launch of YuMOVE, a globally trusted, science-backed joint health supplement. Bascharon was also recently named an EY Entrepreneur of the Year award winner, a true testament to his impact on veterinary innovation and the pet health industry.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related